Invention Grant
- Patent Title: 4-dedimethylamino tetracycline compounds
-
Application No.: US14176923Application Date: 2014-02-10
-
Publication No.: US09278911B2Publication Date: 2016-03-08
- Inventor: Mark L. Nelson , Kwasi Ohemeng
- Applicant: Paratek Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: McCarter & English, LLP
- Agent Elizabeth A. Hanley
- Main IPC: A61K31/65
- IPC: A61K31/65 ; C07C237/26 ; C07C235/70 ; C07C251/48 ; C07C255/41 ; C07C271/22 ; C07C271/54 ; C07C271/58 ; C07C275/42 ; C07C275/54 ; C07C279/18 ; C07C311/06 ; C07C311/08 ; C07C333/08 ; C07C335/22 ; C07C381/10 ; C07D295/155 ; C07D295/185 ; C07D317/60 ; C07F9/24 ; C07F9/40
Abstract:
The present invention pertains, at least in part, to novel substituted 4-dedimethylamino tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Public/Granted literature
- US20150105355A1 4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS Public/Granted day:2015-04-16
Information query
